Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$33.1B
1-Year Return
13.62%
This Quarter Return
+0.29%
1 Year Return
+13.62%
3 Year Return
+68.72%
5 Year Return
+148.95%
10 Year Return
+371.3%
AUM
$16.2B
AUM Growth
-$358M
(-2.2%)
Cap. Flow
-$388M
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
31.94%
Holding
648
New
87
Increased
194
Reduced
199
Closed
94
Top Buys
| 1 |
Merck
MRK
|
$124M |
| 2 |
Meta Platforms (Facebook)
META
|
$120M |
| 3 |
US Bancorp
USB
|
$84.2M |
| 4 |
Johnson & Johnson
JNJ
|
$79.8M |
| 5 |
Keurig Dr Pepper
KDP
|
$74M |
Top Sells
| 1 |
Microsoft
MSFT
|
$185M |
| 2 |
AABA
Altaba Inc. Common Stock
AABA
|
$135M |
| 3 |
Alibaba
BABA
|
$109M |
| 4 |
TWX
Time Warner Inc
TWX
|
$87.8M |
| 5 |
Humana
HUM
|
$86.5M |
Sector Composition
| 1 | Technology | 30.46% |
| 2 | Healthcare | 18.98% |
| 3 | Financials | 11.1% |
| 4 | Communication Services | 9.13% |
| 5 | Consumer Discretionary | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
TD Synnex
SNX
$12.3B
| $710K | ﹤0.01% |
12,000
+2,400
| +25% | +$142K |
|
402
Grupo Aeroportuario Centro Norte
OMAB
$5.07B
| $709K | ﹤0.01% |
+18,000
| New | +$709K |
|
403
Gilead Sciences
GILD
$143B
| $701K | ﹤0.01% |
9,300
| – | – |
|
404
Orthofix Medical
OFIX
$577M
| $699K | ﹤0.01% |
11,900
+5,200
| +78% | +$305K |
|
405
NiSource
NI
$19B
| $691K | ﹤0.01% |
28,900
-329,600
| -92% | -$7.88M |
|
406
Laureate Education
LAUR
$4.13B
| $685K | ﹤0.01% |
49,800
| – | – |
|
407
Skywest
SKYW
$4.52B
| $685K | ﹤0.01% |
12,600
+3,900
| +45% | +$212K |
|
|
PRAH
408
DELISTED
PRA Health Sciences, Inc.
PRAH
| $680K | ﹤0.01% |
8,200
| – | – |
|
409
Stoneridge
SRI
$227M
| $679K | ﹤0.01% |
+24,600
| New | +$679K |
|
410
Bristol-Myers Squibb
BMY
$94.3B
| $677K | ﹤0.01% |
10,700
| – | – |
|
411
Kelly Services Class A
KELYA
$477M
| $677K | ﹤0.01% |
23,300
| – | – |
|
412
United Therapeutics
UTHR
$17.6B
| $674K | ﹤0.01% |
6,000
+3,600
| +150% | +$404K |
|
|
CVG
413
DELISTED
Convergys
CVG
| $674K | ﹤0.01% |
29,800
+1,800
| +6% | +$40.7K |
|
414
Select Medical
SEM
$1.64B
| $668K | ﹤0.01% |
71,827
| – | – |
|
415
Zurn Elkay Water Solutions
ZWS
$7.75B
| $668K | ﹤0.01% |
46,710
-6,851
| -13% | -$98K |
|
416
Revvity
RVTY
$9.94B
| $666K | ﹤0.01% |
8,800
+3,000
| +52% | +$227K |
|
|
CHK
417
DELISTED
Chesapeake Energy Corporation
CHK
| $666K | ﹤0.01% |
1,103
+165
| +18% | +$99.6K |
|
418
AMC Networks
AMCX
$340M
| $662K | ﹤0.01% |
12,800
| – | – |
|
419
Sonic Automotive
SAH
$2.84B
| $661K | ﹤0.01% |
34,900
+7,300
| +26% | +$138K |
|
420
Lantheus
LNTH
$3.63B
| $658K | ﹤0.01% |
41,400
+10,500
| +34% | +$167K |
|
421
Boeing
BA
$174B
| $656K | ﹤0.01% |
2,000
| – | – |
|
422
Verint Systems
VRNT
$1.23B
| $656K | ﹤0.01% |
30,230
-3,534
| -10% | -$76.7K |
|
423
Bio-Rad Laboratories Class A
BIO
$7.81B
| $650K | ﹤0.01% |
2,600
+100
| +4% | +$25K |
|
424
Medpace
MEDP
$13.7B
| $649K | ﹤0.01% |
+18,600
| New | +$649K |
|
|
FBC
425
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $648K | ﹤0.01% |
18,300
+500
| +3% | +$17.7K |
|